Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 38.00
-0.40 (-1.04%)
Apr 29, 2026, 1:06 PM CST
Pharmosa Biopharm Revenue
In the year 2025, Pharmosa Biopharm had annual revenue of 67.27M TWD, down -59.86%. Pharmosa Biopharm had revenue of 47.59M in the quarter ending December 31, 2025, a decrease of -59.34%.
Revenue
67.27M
Revenue Growth
-59.86%
P/S Ratio
73.73
Revenue / Employee
n/a
Employees
40
Market Cap
4.96B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnicoCell Biomed | 30.10M |
| Senhwa Biosciences | 1.07M |
| Medigen Biotechnology | 1.58B |
| Panion & Bf Biotech | 2.06B |
| ACRO Biomedical | 36.50M |
| OBI Pharma | 58.58M |
| Formosa Pharmaceuticals | 9.50M |
| Sagittarius Life Science | 346.08M |